Concise enantioselective synthesis of a key synthetic intermediate for anticancer anthracyclines based on the chemistry of 1-trimethylsilylbuta-2,3-diene
Concise enantioselective synthesis of a key synthetic intermediate for anticancer anthracyclines based on the chemistry of 1-trimethylsilylbuta-2,3-diene